Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05189808 · ClinicalTrials.gov registry record
Radiofrequency Ablation for BIII Thyroid Nodules
A clinical trial of Indeterminate Bethesda III Thyroid Nodules, sponsored by Columbia University.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT05189808: Recruiting study of Indeterminate Bethesda III Thyroid Nodules, sponsored by Columbia University.
NCT05189808 is a study of Indeterminate Bethesda III Thyroid Nodules that is actively recruiting participants, run by Columbia University. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05189808, a study of Indeterminate Bethesda III Thyroid Nodules, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this observational chart review study is to evaluate the efficacy and safety of Radiofrequency Ablation (RFA) for treatment of indeterminate thyroid nodules before and after RFA procedure. This is a data collection study in which the investigators ask patients to give access to information generated before and after RFA treatment of their condition. The RFA procedure uses image guidance to place an electrode through the skin into the target area. In RFA, high-frequency electrical currents are passed through an electrode, creating a small region of heat to treat the lesion.
Primary Outcome
((Volume (baseline) - Volume (12m))/Volume(baseline))\*100
Conditions Studied
Interventions
- PROCEDURE Radiofrequency Ablation
Study Locations (1)
New York
- Columbia University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2027-08 |
What NCT05189808 shows while recruiting
NCT05189808 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 1 condition, with Indeterminate Bethesda III Thyroid Nodules appearing as the primary indexed condition, and to 1 intervention - of which Radiofrequency Ablation is the first listed.
NCT05189808 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05189808 about?
NCT05189808 is a clinical study titled "Radiofrequency Ablation for BIII Thyroid Nodules". The purpose of this observational chart review study is to evaluate the efficacy and safety of Radiofrequency Ablation (RFA) for treatment of indeterminate thyroid nodules before and after RFA procedure. This is a data collection study in which the investigators ask patients to give access to inform...
What is the current status of trial NCT05189808?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2020-08-01. Estimated completion is 2027-08.
What conditions does trial NCT05189808 study?
This clinical trial studies the following conditions: Indeterminate Bethesda III Thyroid Nodules.
What interventions are being tested in trial NCT05189808?
The interventions under investigation include: Radiofrequency Ablation (PROCEDURE).
Who is sponsoring clinical trial NCT05189808?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05189808 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI